Bausch Health Cos Operating Expenses 2010-2024 | BHC

Bausch Health Cos operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Bausch Health Cos Annual Operating Expenses
(Millions of US $)
2023 $7,794
2022 $7,670
2021 $7,984
2020 $7,351
2019 $8,804
2018 $10,764
2017 $8,622
2016 $10,240
2015 $8,920
2014 $6,205
2013 $6,179
2012 $3,401
2011 $2,127
2010 $1,291
2009 $639
Bausch Health Cos Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $2,192
2024-06-30 $2,014
2024-03-31 $1,872
2023-12-31 $2,046
2023-09-30 $2,224
2023-06-30 $1,755
2023-03-31 $1,769
2022-12-31 $2,437
2022-09-30 $1,802
2022-06-30 $1,806
2022-03-31 $1,625
2021-12-31 $1,829
2021-09-30 $1,537
2021-06-30 $2,370
2021-03-31 $2,248
2020-12-31 $2,218
2020-09-30 $1,678
2020-06-30 $1,691
2020-03-31 $1,764
2019-12-31 $3,300
2019-09-30 $1,880
2019-06-30 $1,895
2019-03-31 $1,729
2018-12-31 $2,096
2018-09-30 $2,019
2018-06-30 $2,373
2018-03-31 $4,276
2017-12-31 $2,485
2017-09-30 $2,181
2017-06-30 $2,058
2017-03-31 $1,898
2016-12-31 $2,253
2016-09-30 $3,342
2016-06-30 $2,339
2016-03-31 $2,306
2015-12-31 $2,591
2015-09-30 $2,339
2015-06-30 $2,391
2015-03-31 $1,599
2014-12-31 $1,617
2014-09-30 $1,372
2014-06-30 $1,686
2014-03-31 $1,530
2013-12-31 $1,840
2013-09-30 $2,433
2013-06-30 $954
2013-03-31 $951
2012-12-31 $1,018
2012-09-30 $855
2012-06-30 $733
2012-03-31 $795
2011-12-31 $658
2011-09-30 $488
2011-06-30 $491
2011-03-31 $490
2010-12-31 $564
2010-09-30 $335
2010-06-30 $190
2010-03-31 $203
2009-12-31 $182
2009-09-30 $154
2009-06-30 $183
2009-03-31 $120
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00